Licensing-in/Joint R&D

We have discovered pharmaceuticals based on our own basic research, and have advanced them to clinical trials on our own. In the process, we have successfully developed many drugs and accumulated experience and know-how. In addition, we have a team of highly experienced professionals, including those from major pharmaceutical companies, who are well versed in basic research, non-clinical studies, clinical trials, formulation manufacturing, intellectual property management, and licensing.

On the other hand, the environment surrounding drug discovery ventures is becoming increasingly severe year by year. As a result, many venture companies have gone bankrupt, and the drugs they have developed have disappeared without ever seeing the light of day. In addition, public research institutions such as universities have a lot of research results that could lead to pharmaceuticals, but due to a lack of development funds and know-how, it is very difficult to turn them into pharmaceuticals. This situation is a great loss not only for individual ventures and universities, but also for Japan and mankind as a whole.

Therefore, we have decided to mobilize all of our experience, know-how, and specialized staff in drug development to help other institutions bring their drug seeds to fruition. We will inherit at least part of their intellectual property and develop drugs with our own funds and manpower, but we can also introduce other companies, such as Beijing Tide Pharmaceutical Co., Ltd., or provide consultancy services only, as the case may be.

Meanwhile, the probability of success in drug development is declining in the pharmaceutical industry, and business alliances and risk sharing among companies that leverage each other’s strengths are becoming more important. Therefore, the Company has been considering collaborating with companies with outstanding technologies and pipelines to conduct joint drug development, and as the first such project, the Company has been conducting joint development with Nobelpharma Co., Ltd. (“Nobelpharma”) since 2018. Nobelpharma and our company have an agreement to jointly conduct drug development (clinical trials) and share the profits obtained. Nobelpharma has launched numerous drugs and medical devices with an outstanding success rate due to its strong development capabilities. The company specializes in clinical development, regulatory filings, and marketing, and we believe that collaboration with us, an R&D-oriented company, will produce high synergy effects. We would like to promote such joint development in the future and look forward to receiving your proposals.